↓ Skip to main content

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

Overview of attention for article published in BMC Cancer, February 2013
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
60 Mendeley
Title
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study
Published in
BMC Cancer, February 2013
DOI 10.1186/1471-2407-13-56
Pubmed ID
Authors

Francesco Russo, Michele Linsalata, Caterina Clemente, Benedetta D’Attoma, Antonella Orlando, Giovanna Campanella, Francesco Giotta, Giuseppe Riezzo

Abstract

Several GI peptides linked to intestinal barrier function could be involved in the modification of intestinal permeability and the onset of diarrhea during adjuvant chemotherapy. The aim of the study was to evaluate the circulating levels of zonulin, glucagon-like peptide-2 (GLP-2), epidermal growth factor (EGF) and ghrelin and their relationship with intestinal permeability and chemotherapy induced diarrhea (CTD).

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 59 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 17%
Student > Ph. D. Student 10 17%
Student > Master 9 15%
Student > Doctoral Student 6 10%
Unspecified 6 10%
Other 19 32%
Readers by discipline Count As %
Medicine and Dentistry 20 33%
Agricultural and Biological Sciences 11 18%
Immunology and Microbiology 7 12%
Unspecified 6 10%
Biochemistry, Genetics and Molecular Biology 5 8%
Other 11 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2013.
All research outputs
#2,742,825
of 3,635,050 outputs
Outputs from BMC Cancer
#1,235
of 1,788 outputs
Outputs of similar age
#207,516
of 281,216 outputs
Outputs of similar age from BMC Cancer
#68
of 100 outputs
Altmetric has tracked 3,635,050 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,788 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,216 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.